Author Correction: ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response

Affiliations

• ¹ CRUK Cambridge Institute, University of Cambridge, Cambridge, UK.
• ² Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.
• ³ Wellcome Trust Sanger Institute, Hinxton, UK.
• ⁴ The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
• ⁵ Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
• ⁶ CRUK Cambridge Institute, University of Cambridge, Cambridge, UK. [email protected].